• Issue

    Clinical & Translational Immunology: Volume 13, Issue 2

    2024

Original Article

Open Access

γδ T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expression

  • First Published: 29 January 2024
γδ T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expression

We assessed the phenotype and function of Vδ1 and Vδ2 T cells in the context of antiretroviral therapy (ART) treated HIV-1 infection. Despite exhibiting elevated expression of immune checkpoint molecules in comparison to uninfected controls, both γδ T cell subsets remained capable of robust anti-HIV effector functions in ART-treated people living with HIV.

Short Communication

Open Access

SARS-CoV-2-associated T-cell infiltration in the central nervous system

  • First Published: 31 January 2024
SARS-CoV-2-associated T-cell infiltration in the central nervous system

In COVID-19 patients, neurological symptoms and complications are increasingly recognised, but their underlying causes remain poorly understood. This study found that SARS-CoV-2-associated T cells were present in various brain regions of patients who had fatal COVID-19 pneumonia, with the olfactory bulb, medulla and cerebellum showing the most specific patterns. These T cells primarily consisted of CD8+ T cells and were localised around blood vessels. Further research is required to fully understand the connection between T-cell infiltration in the brain and its impact on patients' cognitive and mental health in the long term.

Original Article

Open Access

Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients

  • First Published: 05 February 2024
Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients

In this study, we found that tertiary lymphoid structures (TLSs) are anti-tumor element of tumor immune microenvironment in patients with resected gastric neuroendocrine neoplasm (GNEN). High infiltration of TLSs is an independent and favourable prognosis predictor for GNENs. Our findings indicate that nomograms including TLS density can predict prognosis of GNEN patients more precisely.

Review

Open Access

Fighting flu: novel CD8+ T-cell targets are required for future influenza vaccines

  • First Published: 14 February 2024
Fighting flu: novel CD8+ T-cell targets are required for future influenza vaccines

Seasonal influenza viruses continue to cause severe medical and financial complications annually despite vaccines being available. As such, there is a need for updated vaccines that provide long-lasting protection to global populations. In this review, we summarise licenced influenza vaccines and those currently in clinical trials, highlighting their key advantages and limitations. Furthermore, we discuss activating CD8+ T cells for future influenza vaccinations, highlighting the current gaps in knowledge for rational vaccine design.

Original Article

Open Access

Whole blood transcriptomics reveals granulocyte colony-stimulating factor as a mediator of cardiopulmonary bypass-induced systemic inflammatory response syndrome

  • First Published: 19 February 2024
Whole blood transcriptomics reveals granulocyte colony-stimulating factor as a mediator of cardiopulmonary bypass-induced systemic inflammatory response syndrome

Systemic inflammatory response syndrome (SIRS) is a major complication associated with cardiopulmonary bypass (CPB). In this study, we used whole blood transcriptomics to reveal neutrophils and G-CSF as major regulators of CPB-induced systemic inflammation. Our results suggest that short-term targeting of G-CSF could provide a novel therapeutic strategy to limit neutrophil-mediated inflammation and tissue damage in SIRS induced by CPB.

Reviews

Open Access

Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy

  • First Published: 19 February 2024
Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy

The clinical efficacy of γδ T-cell immunotherapies is limited by issues with the pharmacodynamic/pharmacokinetic profiles of commonly used agonists, an inability of administered T cells to infiltrate into solid tumours and limited knowledge of γδ T-cell checkpoint inhibition. This article reviews the current state of γδ T-cell immunotherapy and offers viable strategies to enhance the clinical efficacy of this promising cancer treatment.

Case Report

Open Access

Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation

  • First Published: 26 February 2024
Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation

We report the clinical and immune features of 7 individuals from the same kindred with a novel genetic variant in RAC2 (c.62T > G, p.I21S). We provide evidence that this is a dominant activating (DA) variant causing notable morphological and functional abnormalities similar to other reported DA mutations. This novel variant expands the phenotypic spectrum of RAC2 DA lesions, emphasising the need to tailor clinical management according to patients' disease phenotype and severity.